Persistence of MR3 in Chronic Myeloid Leukemia (CML) After a 2nd Stop of TKI Treatment
Clinical trial NCT03573596 · UNKNOWN
Trial details
- NCT number
- NCT03573596
- Sponsor
- Amsterdam UMC, location VUmc
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-01
- Primary completion
- 2023-02-01
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.